drugset / Trial / NCT07448155
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is being conducted to evaluate the pharmacokinetics, safety, and tolerability of INCA033989 following subcutaneous (SC) or intravenous administration (IV) n healthy adult participants.
Timeline
- Start
- 2026-03-19
- Primary completion
- 2026-10-19
- Completion
- 2026-10-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INCA033989 | Unknown | — | Subcutaneous |
Indications
No indication recorded.